
    
      The Centaur Open Label Extension Study (CENTAUR-OLE) is designed to provide longer term
      access to AMX0035 for patients with ALS who participated in the CENTAUR study. The study will
      assess longer term safety and therapeutic potential of AMX0035.
    
  